She received her veterinary degree from the Royal Veterinary College, University of London and her PhD in Immunology from the University of Pennsylvania. She performed her post-doctoral research at the University of Pennsylvania’s School of Medicine. Taking a comparative approach to overcome some of the intrinsic limitations of rodent model systems, Dr. Mason’s translational research group focuses on evaluating the safety and therapeutic effect of immunotherapies in pet dogs with spontaneous cancer and autoimmunity. Results from well-designed, appropriately controlled clinical trials in veterinary patients are used to identify correlative biomarkers of response and inform human clinical trial design.